bioRxiv/medRxiv TRiP Review Activity

268 Reviews — eLife — Cancer Biology

Most recent first Previous |  Page 12: Articles 111-120  | Next

RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer
Liu, Y., Jiang, Y., Qiu, P., Ma, T., Bu, J., Hu, Y., Jin, M., Zhu, T., Gu, X.
10.1101/2024.03.04.583283 — Posted: 2024-03-06 — Discussion: 2024-05-23  eLife
Comparison of Tug-of-War Models Assuming Moran versus Branching Process Population Dynamics
Dinh, K. N., Kurpas, M. K., Kimmel, M.
10.1101/2023.10.20.563302 — Posted: 2023-10-23 — Discussion: 2024-05-21  eLife
Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia
Spinler, K., Hamilton, M., Bajaj, J., Shima, Y., Diaz, E., Kritzik, M., Reya, T.
10.1101/2023.12.29.573601 — Posted: 2023-12-29 — Discussion: 2024-05-10  eLife
RAPSYN-Mediated Neddylation of BCR-ABL Alternatively Determines the Fate of Philadelphia Chromosome-positive Leukemia
Zhao, m., Dai, B., Li, X., Zhang, Y., Qiao, C., Qin, Y., Li, Z., Li, Q., Wang, S., Yang, Y., Chen, Y.
10.1101/2023.05.24.542110 — Posted: 2023-05-25 — Discussion: 2024-05-02  eLife
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A. A. I., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., Crowder, K. D., Kent, J. R., Madariaga, M. L. L., Jain, R. K., Beckermann, K. E., Lewis, C. A., Clish, C. B., Muir, A., Rathmell, W. K., Rathmell, J. C., Vander Heiden, M. G.
10.1101/2023.12.24.573250 — Posted: 2023-12-24 — Discussion: 2024-04-30  eLife
mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated non-degradative ubiquitination of eIF4A1
Sun, H., Jiao, D., Zhao, X., Chen, Y., Shi, Q., Lv, Z., Li, Y., Gao, K., Wang, C.
10.1101/2023.09.27.559872 — Posted: 2023-09-29 — Discussion: 2024-04-26  eLife
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Howard, G. C., Wang, J., Rose, K. L., Patel, P., Tsui, T., Florian, A. C., Lorey, S. L., Grieb, B. C., Smith, B. N., Slota, M. J., Reynolds, E. M., Goswami, S., Savona, M. R., Lee, T., Fesik, S. W., Liu, Q., Tansey, W. P.
10.1101/2023.07.26.550648 — Posted: 2023-07-29 — Discussion: 2024-04-09  eLife
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
Pineda, J. M. B., Bradley, R. K.
10.1101/2023.07.10.548412 — Posted: 2023-07-11 — Discussion: 2024-04-08  eLife
mitoBKCa is functionally expressed in murine and human breast cancer cells and promotes metabolic reprogramming
Bischof, H., Maier, S., Koprowski, P., Kulawiak, B., Burgstaller, S., Jasinska, J., Serafimov, K., Gross, D., Schroth, W., Matt, L., Juarez Lopez, D. A., Bonzheim, I., Büttner, F. A., Fend, F., Schwab, M., Birkenfeld, A. L., Malli, R., Lämmerhofer, M., Bednarczyk, P., Szewczyk, A., Lukowski, R.
10.1101/2023.10.02.560571 — Posted: 2023-10-04 — Discussion: 2024-04-05  eLife
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
Mullen, N. J., Shukla, S. K., Thakur, R., Kollala, S. S., Wang, D., Chaika, N., LaBreck, D. A., Mallareddy, J. R., Price, D., Natarajan, A., Mehla, K., Sykes, D. B., Hollingsworth, M. A., Singh, P. K.
10.1101/2023.04.03.535399 — Posted: 2023-04-05 — Discussion: 2024-04-04  eLife

Evaluation Sources